Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Published human evidence includes topical applications over defined periods, diabetic-ulcer wound protocols, and a registered topical acute-wound trial, while there is no FDA-approved injectable GHK-Cu label that establishes a standard dose [2], [3], [7], [8]
( ) : - ,
Method Quick intramuscular or subcutaneous injections
Equipment: 29 to 31 gauge insulin syringe, 0.5 inch needle length
Current reviews describe limited and inconsistent evidence for cosmetic outcomes, especially by the intravenous route
.jpg)
Most injectable peptides promoted for knee healing, including BPC-157 and TB-500, are not approved by the Therapeutic Goods Administration (TGA) for therapeutic use in Australia
